Side-by-side comparison of AI visibility scores, market position, and capabilities
Atonarp develops real-time molecular analysis systems for semiconductor fabrication processes, enabling in-situ gas monitoring and process control.
Atonarp is a deep-tech sensing company with headquarters in Osaka, Japan and operations in San Jose, California that develops mass spectrometry-based molecular sensing instruments designed for in-situ, real-time analysis of process gases and chemical environments inside semiconductor fabrication equipment. The company was founded with the premise that semiconductor manufacturing process control is constrained by the inability to measure the actual chemical composition of processes as they occur inside the reactor chamber — current process control relies primarily on indirect sensors like pressure, temperature, and power measurements that correlate with process conditions but do not directly measure the chemical species being deposited or etched. Atonarp's molecular sensing technology provides direct, real-time chemical composition data from inside the process environment, enabling a new class of process control that responds to actual chemical state rather than inferred process conditions.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.